“…As with other large DNA viruses, interest exists in the use of recombinant BHV-1 as an improved live vaccine against BHV-1 infection (1,21,42) or as a vector for bi-or multivalent vaccines against BHV-1 and additional bovine pathogens (17,18). To date, incorporation of heterologous genes into the genome of BHV-1 has concentrated mainly on the expression of the procaryotic lacZ gene to identify essential and nonessential genes or as a reporter gene for analytical studies (3,8,12,15,20,29,37,38,45). Recently, BHV-1 has been used to express biologically active bovine interleukins (21,32) and glycoproteins of pseudorabiesvirus (19,31).…”